Epigenetic Alterations as Cancer Diagnostic, Prognostic, and Predictive Biomarkers

This publication has 265 references indexed in Scilit:

• Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis
  Biomedicine & Pharmacotherapy, 2010
• Implication of microRNAs in drug resistance for designing novel cancer therapy
  Drug Resistance Updates, 2010
• microRNAs and lung cancer: tumors and 22-mers
  Cancer and Metastasis Reviews, 2010
• DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
  Cancer Cell, 2010
• RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
  Cell, 2009
• RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
  Gynecologic Oncology, 2008
• Tissue Inhibitor of Metalloproteinases-3 Promoter Methylation is an Independent Prognostic Factor for Bladder Cancer
  Journal of Urology, 2008
• MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
  JAMA, 2008
• Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphoma
  International Journal of Cancer, 2007
• Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis
  Breast Cancer Research and Treatment, 2005